FacebookTwitterYouTubeInstagramLinkedInWhatsapp

    Sanofi launches MS treatment drug in India

    2018-08-09T10:33:01+00:00August 8th, 2018|Uncategorized|

    French drug firm Sanofi said its speciality care global business unit Sanofi Genzyme has launched its multiple sclerosis (MS) treatment drug Aubagio in India. The drug offers patients diagnosed with multiple sclerosis the efficacy and convenience of once-a-day oral treatment, Sanofi Genzyme said in a statement. N. Rajaram, Sanofi India MD, said: “For over a decade Sanofi has invested in developing and delivering novel therapeutic solutions for the treatment of multiple sclerosis around the world; and is now bringing Aubagio, [...]

    Read More

      Indian companies take off in EU

      2018-08-01T12:04:35+00:00December 20th, 2017|2017/2018, December 2017, INDIA-EU, Year|

      The civil aviation sector was at the heart of the bond between India and the European Union (EU) in recent weeks. India clears aviation MoU with Poland The Union Cabinet of India, chaired by the Prime Minister Narendra Modi, has given its approval for signing the memorandum of understanding (MoU) between India and Poland for the Promotion of Civil Aviation Cooperation. The MoU, which will be for a term of five years, will be signed on behalf of the two [...]

      Read More

        India is at a cusp of a revolution

        2020-03-26T07:08:21+00:00October 27th, 2017|2017/2018, GLOBAL INDIAN, October 2017, Year|

        Dr B.R. Shetty is the Founder and Non-Executive Chairman of the Abu Dhabi based NMC Healthcare and Chairman of UAE Exchange, which most recently hit the headlines for its acquisition of forex major Travelex. The Karnataka-born and UAE-based entrepreneur opens up to ‘India Global Business’ on his journey, his inspirations and future plans. What makes the UAE a good base for your enterprises? In the last four decades, I have learnt so much about different cultures, made many Emirati friends [...]

        Read More

          Short Takes

          2018-12-31T12:03:58+00:00September 12th, 2017|2018/2017, India Investment Journal September Edition, India-Japan, Year|

          Japan’s NTT eyes India growth Japan’s NTT Communications Corporation (NTT Com), an ICT solutions and international communications business within the NTT Group, has announced the launch of its international data network services in India through its affiliate NTT Communications India Network Services (NTTCINS). The acquisition of this licence in India follows the initiation of construction of the company’s two new data centres in Mumbai and Bangalore, through Netmagic, a subsidiary of NTT Com and one of the leading managed hosting [...]

          Read More

            Indian healthcare: An emerging investment magnet

            2018-12-03T11:58:06+00:00May 26th, 2017|2018/2017, India Investment Journal January Edition, India Investment Journal May Edition, Other Highlights, Policy India, Year|

            The Indian healthcare sector is riding the growth curve and emerging as a lucrative site for foreign investments, writes a healthcare analyst. The Indian healthcare sector is one of the fastest growing sectors with high contribution not only in terms of revenue, but also employment. The Indian healthcare market is expected to rank amongst the top-three healthcare markets in terms of incremental growth by 2020.[1] The sector stood at approximately $113.9 billion in 2016 and is likely to grow at [...]

            Read More

              Britain holds on to position as largest G20 investor into India

              2018-12-03T12:53:10+00:00March 15th, 2017|2018/2017, India Investment Journal March Edition, India-UK, Year|

              Britain beat off tough competition from Japan to hold on to its position as the largest G20 investor and biggest job creator in India, a new report revealed. Between 2000 and 2016, the UK invested $24.07 billion in India and created 371,000 jobs, the Confederation of British Industry (CBI) finds in its 2017 ‘Sterling Assets India’ report. Japan by comparison invested around $23.76 billion, followed by the US at $19.38 billion as the top G20 investors into India. “The top [...]

              Read More

                India: The world’s friendly drug supplier

                2018-08-07T08:04:05+00:00February 9th, 2017|2017/2018, February 2017, Sector Focus/Pharma, Year|

                The Indian pharmaceutical industry is holding on to a sliver of hope that it could become the supplier of choice for the US market. Indian IT sector CEOs aren’t the only ones weighing every word uttered by US President Donald Trump for nuances and burning the midnight oil wondering how to maintain their lead in their largest market. IT’s less glamorous but equally successful knowledge sector cousin, the Indian pharmaceuticals industry, is also worried about how the new US administration’s [...]

                Read More

                  Affordable bio-pharma innovation that is Made in India

                  2018-08-06T13:39:21+00:00February 9th, 2017|2017/2018, February 2017, Sector Focus/Pharma, Year|

                  Kiran Mazumdar-Shaw is a consistent presence on definitive global lists as one of the world’s most powerful women. As the Chairman and Managing Director of Biocon Limited, she is a trendsetter in the field of biotechnology in India. Here she takes time out for ‘India Global Business’ to give us an insight into her entrepreneurial drive and India’s own biotech journey. How has India's biotech sector grown since you entered as a pioneer in the field? The Indian biotech industry [...]

                  Read More
                  Toggle Sliding Bar Area